secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2022-08-25T23:59:59+00:00
Accession:  0000010795-22-000059
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD appoints Garrison as Medical segment president and Byrd as Interventional segment president; Campion departs
--------------------------------------------------------------------------------

- Michael Garrison named EVP & President, Medical segment, effective Sept 6, 2022; previously led Medication Management Solutions.
- Richard Byrd named EVP & President, Interventional segment, effective Sept 6, 2022; previously led Medication Delivery Solutions.
- Simon Campion to depart BD on Sept 9, 2022 for executive role elsewhere; he joined via C.R. Bard acquisition.
- Both Garrison and Byrd report to CEO Tom Polen and join Executive Leadership Team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/bdx-20220822.htm
  HTML page:      https://secwatch.observer/filing/0000010795-22-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer